First Turn Management, LLC
- SEC CIK
- 0001993440
- Latest filing
- Aug 14, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 6, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 34
- +3 vs. Q4 2023
- Portfolio value
- $668.5M
- −$27.9M (−4.0%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SWAVShockwave Medical, Inc. | COM | 98,111 | $31.9M | 4.8% | +40,627+70.7% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 79,978 | $31.5M | 4.7% | −3,425−4.1% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 430,349 | $30.2M | 4.5% | −377,095−46.7% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 680,389 | $29.3M | 4.4% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 221,748 | $28.7M | 4.3% | +17,866+8.8% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 342,173 | $27.3M | 4.1% | +46,745+15.8% | Added | History |
| DXCMDexcom Inc | COM | 192,932 | $26.8M | 4.0% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 394,674 | $25.7M | 3.8% | +51,595+15.0% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 379,803 | $25.2M | 3.8% | +379,803 | New | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 58,832 | $24.6M | 3.7% | −22,851−28.0% | Reduced | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 958,654 | $24.1M | 3.6% | +122,352+14.6% | Added | History |
| BHVNBiohaven Ltd. | COM | 432,342 | $23.6M | 3.5% | −44,972−9.4% | Reduced | History |
| KRYSKrystal Biotech, Inc. | COM | 130,850 | $23.3M | 3.5% | −111,335−46.0% | Reduced | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 151,587 | $22.9M | 3.4% | 00.0% | Unchanged | History |
| TMDXTransMedics Group, Inc. | COM | 297,377 | $22.0M | 3.3% | −25,808−8.0% | Reduced | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,318,207 | $21.8M | 3.3% | −382,742−22.5% | Reduced | History |
| NUVLNuvalent, Inc. | COM | 265,897 | $20.0M | 3.0% | +10,000+3.9% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 421,487 | $18.3M | 2.7% | +64,808+18.2% | Added | History |
| PCVXVaxcyte, Inc. | COM | 260,281 | $17.8M | 2.7% | −97,247−27.2% | Reduced | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 464,435 | $17.6M | 2.6% | +464,435 | New | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 397,782 | $17.5M | 2.6% | +15,400+4.0% | Added | History |
| IMVTImmunovant, Inc. | COM | 512,893 | $16.6M | 2.5% | 00.0% | Unchanged | History |
| IRONDisc Medicine, Inc. | COM | 252,673 | $15.7M | 2.4% | +95,399+60.7% | Added | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 973,130 | $15.7M | 2.3% | −233,161−19.3% | Reduced | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,097,571 | $15.1M | 2.3% | +1,097,571 | New | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 206,707 | $14.3M | 2.1% | −10,718−4.9% | Reduced | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,179,420 | $14.0M | 2.1% | +1,179,420 | New | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 990,618 | $13.7M | 2.0% | +990,618 | New | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 228,251 | $12.8M | 1.9% | −247,828−52.1% | Reduced | History |
| EYPTEyePoint, Inc. | COM NEW | 585,447 | $12.1M | 1.8% | +268,437+84.7% | Added | History |
| VKTXViking Therapeutics, Inc. | COM | 128,064 | $10.5M | 1.6% | +128,064 | New | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 250,870 | $6.76M | 1.0% | +250,870 | New | History |
| TYRATyra Biosciences, Inc. | COM | 381,210 | $6.25M | 0.9% | +381,210 | New | History |
| VERAVera Therapeutics, Inc. | CL A | 118,260 | $5.10M | 0.8% | +118,260 | New | History |
Sold out since Q4 2023 (6)
Positions held at the end of Q4 2023 that are gone from this filing.
| Security | Class | Shares in Q4 2023 | Value in Q4 2023 | % of portfolio in Q4 2023 | History |
|---|---|---|---|---|---|
| CBAYCymaBay Therapeutics, Inc. | COM | 1,497,331 | $35.4M | 5.1% | History |
| KRTXKaruna Therapeutics, Inc. | COM | 87,369 | $27.7M | 4.0% | History |
| PODDInsulet Corp | Stock | 115,366 | $25.0M | 3.6% | History |
| ROIVRoivant Sciences Ltd. | SHS | 1,363,504 | $15.3M | 2.2% | History |
| CABACabaletta Bio, Inc. | COM | 175,359 | $3.98M | 0.6% | History |
| SLGCWSomaLogic, Inc. | *W EXP 03/01/202 | 17,953 | $2.15K | <0.1% | History |